Abstract
Background: Smoking in any form is a significant risk factor for developing cardiovascular diseases, chronic obstructive pulmonary disease, lung cancer, and other oxidative damage-induced diseases. The increasing global trend of E-cigarettes has led traditional smokers to perceive them as a safer option.
Objectives: This study aimed to compare the levels of malondialdehyde (MDA) as a marker of oxidative damage and high-sensitivity C-reactive protein (hs- CRP) as a marker of inflammation between pure E-cigarette users and tobacco poly-users (smoking combinations of traditional products). Moreover, it also evaluated the influence of Body Mass Index, frequency, and duration of vaping/smoking on these biomarkers.
Materials and Methods: This analytical cross-sectional pilot study included 40 males aged 18-25 (20 pure E-cigarette users and 20 tobacco poly-users). MDA and hs-CRP were estimated on serum, and SPSS-Version 28.0.1.1 was used for data analysis. Mean hs-CRP and MDA levels for the two groups were compared using the Mann-Whitney-U test.
Results: Mean level of hs-CRP between the two groups was not significantly different. However, MDA levels were lower in pure E-cigarette users than in tobacco poly-users, especially among those with normal BMI and those who vaped/smoked more frequently and for a longer duration.
Conclusion: Oxidative damage was lesser for pure E-cigarette users and could potentially be the less harmful option than tobacco poly-use. However, Ecigarettes are not the safest substitute for conventional smoking as it causes a similar extent of risk for inflammation-related CVD. Findings need further exploration to study the long-term effects on a larger population group to draw definitive conclusions.
Keywords: E-cigarettes, High sensitivity C-reactive protein (hs-CRP), Inflammation, Malondialdehyde (MDA), Oxidative damage, Tobacco polyuse, Vaping.
[http://dx.doi.org/10.3390/ijerph18147652] [PMID: 34300103]
[http://dx.doi.org/10.1093/ntr/ntu176] [PMID: 25180080]
[http://dx.doi.org/10.1371/journal.pone.0170249] [PMID: 28166540]
[http://dx.doi.org/10.3389/fimmu.2018.00754] [PMID: 29706967]
[http://dx.doi.org/10.1111/j.1742-1241.2009.02179.x] [PMID: 19732183]
[PMID: 25878632]
[http://dx.doi.org/10.1016/j.cca.2007.01.028] [PMID: 17336279]
[http://dx.doi.org/10.3329/jbsp.v10i1.24617]
[http://dx.doi.org/10.1385/0-89603-472-0:107] [PMID: 9921520]
[http://dx.doi.org/10.14485/HBPR.6.5.2] [PMID: 32490030]
[http://dx.doi.org/10.1152/ajplung.00110.2019] [PMID: 31042077]
[http://dx.doi.org/10.1186/s12889-020-08858-4] [PMID: 32414354]
[http://dx.doi.org/10.1016/j.yrtph.2012.08.006] [PMID: 22951349]
[http://dx.doi.org/10.1177/0091270008315316] [PMID: 18319361]
[http://dx.doi.org/10.1189/jlb.3AB0815-379RR] [PMID: 27312847]
[http://dx.doi.org/10.3389/fcvm.2021.630968] [PMID: 33708805]
[http://dx.doi.org/10.1186/1479-5876-9-129] [PMID: 21810260]
[http://dx.doi.org/10.3390/antiox11091829] [PMID: 36139904]
[http://dx.doi.org/10.32883/hcj.v5i1.636]
[http://dx.doi.org/10.22159/ijcpr.2019v11i3.34084]
[http://dx.doi.org/10.3390/ijms12053117] [PMID: 21686173]
[http://dx.doi.org/10.1161/CIRCULATIONAHA.117.029153] [PMID: 29335291]
[http://dx.doi.org/10.1097/ADM.0000000000000272] [PMID: 27898495]
[http://dx.doi.org/10.46308/kmj.2022.00157]
[http://dx.doi.org/10.1038/s41598-018-29867-9] [PMID: 30150729]